Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Henry Schein    HSIC

HENRY SCHEIN (HSIC)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
02/15/2018 02/16/2018 02/20/2018 02/21/2018 02/22/2018 Date
68.38(c) 69.52(c) 67.97(c) 68.68(c) 67.97(c) Last
2 146 941 2 869 596 4 500 482 3 136 838 1 891 763 Volume
-0.07% +1.67% -2.23% +1.04% -1.03% Change
More quotes
Financials ($)
Sales 2018 13 247 M
EBIT 2018 927 M
Net income 2018 618 M
Debt 2018 1 316 M
Yield 2018 -
Sales 2019 13 898 M
EBIT 2019 982 M
Net income 2019 673 M
Debt 2019 1 121 M
Yield 2019 -
P/E ratio 2018 16,96
P/E ratio 2019 15,51
EV / Sales2018 0,91x
EV / Sales2019 0,86x
Capitalization 10 780 M
More Financials
Company
Henry Schein, Inc. engages in the provision of providing health care products and services to medical, dental, and veterinary office-based practitioners.It operates through the following business segments: Healthcare Distribution, and Technology & Value-Added Services.The Healthcare Distribution... 
More about the company
Surperformance© ratings of Henry Schein
Trading Rating : Investor Rating :
More Ratings
Latest news on HENRY SCHEIN
02:17pHENRY SCHEIN : Animal Health's Canine Influenza Resource Center Helps Raise Awar..
PU
02/21HENRY SCHEIN : Management's Discussion and Analysis of Financial Condition and R..
AQ
02/20HENRY SCHEIN INC : Results of Operations and Financial Condition, Financial Stat..
AQ
02/20HENRY SCHEIN : reports 4Q loss
AQ
02/20HENRY SCHEIN : Reports Record Fourth Quarter and Full Year 2017 Financial Result..
PR
02/19HENRY SCHEIN : And Its Dental Laboratory Business, Zahn Dental, To Showcase The ..
PU
02/19CROWN COUNCIL : Names Henry Schein Cares Its Humanitarian Partner Of The Year At..
PR
02/15HENRY SCHEIN : Pawar Law Group Announces Investigation of Securities Claims Agai..
AC
02/15HENRY SCHEIN : INVESTOR NOTICE: The Schall Law Firm Announces the Investigation ..
AC
02/15HENRY SCHEIN Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Ex..
BU
More news
Sector news : Medical Equipment Wholesale
02/21OMAR ISHRAK : Pay if It Works -- WSJ
DJ
02/20MEDTRONIC : U.S. Revenue Drops -- Earnings Review
DJ
02/20MEDTRONIC MOVES TO A NEW HEALTH-CARE : Pay Only if It Works
DJ
02/15STRYKER : U.S. Regulators Extend Window for Critical Stroke Treatment
DJ
02/15STRAUMANN : margin outlook takes shine off revenue surge
RE
More sector news : Medical Equipment Wholesale
4-Traders Strategies on HENRY SCHEIN 
HENRY SCHEIN, INC. - 2017
Towards the breakout of a major resistance level
BUY
HENRY SCHEIN, INC. - 2017
No turn-around in sight
BUY
More Strategies
Latest Tweets
08:05pRep. David McKinley briefly detained in Israel
1
04:49pJefferies Group Raises Henry Schein Q3 2018 Earnings Estimates to $1.02 EPS (.. 
03:09pHenry Schein Animal Health's Canine Influenza Resource Center Helps Raise Awa.. 
02:15pQ1 2018 EPS Estimates for Henry Schein, Inc. $HSIC Cut by Barrington Research.. 
02:09p$HSIC Henry Schein Animal Health's Canine Influenza Resource Center Helps Rai.. 
More tweets
Qtime:106
News from SeekingAlpha
02/21Henry Schein, Inc. 2017 Q4 - Results - Earnings Call Slides 
02/20Henry Schein's CEO Stanley Bergman on (HSIC) Q4 2017 Results - Earnings Call .. 
02/20Henry Schein EPS in-line, beats on revenue 
02/19Notable earnings before Tuesday?s open 
02/15Premarket analyst action - healthcare 
Chart HENRY SCHEIN
Duration : Period :
Henry Schein Technical Analysis Chart | HSIC | US8064071025 | 4-Traders
Technical analysis trends HENRY SCHEIN
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Average target price 78,6 $
Spread / Average Target 14%
EPS Revisions
Managers
NameTitle
Stanley M. Bergman Chairman & Chief Executive Officer
James P. Breslawski President & Director
Steven Paladino Chief Financial Officer, Director & Executive VP
James A. Harding Chief Technology Officer & Senior Vice President
Philip A. Laskawy Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
HENRY SCHEIN-2.73%10 780
COLOPLAST A/S5.94%17 052
CANTEL MEDICAL CORP.9.25%4 790
AMPLIFON SPA4.52%3 726
PATTERSON COMPANIES-12.54%3 038
MERIT MEDICAL SYSTEMS, INC.5.32%2 302